(Stasch et al., 2006) Based on these results, new active ingredients for the treatment of pulmonary hypertension and cardiac dysfunction have been developed, and several highly cited papers have been published in high impact journals, indicating that Professor Stasch JP’s research has a significant influence on sGC stimulators in CV research. The gene discussed is SGCB; the disease is pulmonary arterial hypertension.